Skip to main content

1620 INVESTMENT ADVISORS, INC.

Position in GILD — Gilead Sciences, Inc.

CIK 1907281 PLYMOUTH, MA

Position in GILD

as of Jun 30, 2026 · filed Jul 14, 2026
Position Value
$755,007
-$174,869 QoQ
Shares Held
5,976
-10.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.72%
of 13F equity value
Holder Rank
#1,201
of 2,266 holders
Holding Since
Dec 2021
17 quarters on record
Voting authority Sole 50% Shared 0% None 50%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

1620 INVESTMENT ADVISORS, INC. holds $6,968,762 across 10 Drug Manufacturers - General names. GILD ranks #5 (10.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 GILD
Gilead Sciences, Inc.
This page
5,976 $755,007

All Filings in GILD

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $755,007 5,976
2026-03-31 $929,876 6,672
2025-12-31 $794,741 6,475
2025-09-30 $717,837 6,467
2025-06-30 $723,315 6,524
2025-03-31 $701,545 6,261
2024-12-31 $571,308 6,185
2024-09-30 $490,212 5,847
2024-06-30 $402,877 5,872
2024-03-31 $429,904 5,869
2023-12-31 $660,798 8,157
2023-09-30 $663,593 8,855
2023-06-30 $700,951 9,095
2023-03-31 $772,699 9,313
2022-12-31 $821,927 9,574
2022-03-31 $597,056 10,043
2021-12-31 $729,222 10,043